ALEXION PHARMACEUTICALS, INC. Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 171.15 | 1,985 | 339,733 | 162,708 | 164.7 K to 162.7 K (-1.21 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 171.15 | 795 | 136,064 | 23,555 | 24.4 K to 23.6 K (-3.26 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Sell | S | 171.15 | 325 | 55,624 | 5,213 | 5.5 K to 5.2 K (-5.87 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 176.91 | 1,907 | 337,367 | 32,219 | 34.1 K to 32.2 K (-5.59 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 171.15 | 1,990 | 340,589 | 34,126 | 36.1 K to 34.1 K (-5.51 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 171.15 | 1,490 | 255,014 | 26,777 | 28.3 K to 26.8 K (-5.27 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | EVP, Chief Strat & ... | Sell | S | 171.15 | 1,500 | 256,725 | 34,560 | 36.1 K to 34.6 K (-4.16 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 171.15 | 1,490 | 255,014 | 21,670 | 23.2 K to 21.7 K (-6.43 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 171.15 | 1,980 | 338,877 | 124,033 | 126 K to 124 K (-1.57 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 171.15 | 5,740 | 982,401 | 944,308 | 950 K to 944.3 K (-0.60 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 175.09 | 2 | 350 | 164,693 | 164.7 K to 164.7 K (0.00 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.18 | 2,701 | 470,460 | 164,695 | 167.4 K to 164.7 K (-1.61 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 11,690 | 0 | 167,396 | 155.7 K to 167.4 K (+7.51 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Grant | A | 0.00 | 4,350 | 0 | 24,350 | 20 K to 24.4 K (+21.75 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 174.16 | 1,455 | 253,403 | 28,267 | 29.7 K to 28.3 K (-4.90 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 8,760 | 0 | 29,722 | 21 K to 29.7 K (+41.79 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Grant | A | 0.00 | 2,538 | 0 | 5,538 | 3 K to 5.5 K (+84.60 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 11,690 | 0 | 36,116 | 24.4 K to 36.1 K (+47.86 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Grant | A | 0.00 | 8,760 | 0 | 36,060 | 27.3 K to 36.1 K (+32.09 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 173.75 | 1,665 | 289,294 | 23,160 | 24.8 K to 23.2 K (-6.71 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Grant | A | 0.00 | 8,760 | 0 | 24,825 | 16.1 K to 24.8 K (+54.53 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 173.93 | 2,920 | 507,876 | 126,013 | 128.9 K to 126 K (-2.26 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 11,690 | 0 | 128,933 | 117.2 K to 128.9 K (+9.97 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 173.98 | 8,660 | 1,506,667 | 950,048 | 958.7 K to 950 K (-0.90 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 0.00 | 33,990 | 0 | 958,708 | 924.7 K to 958.7 K (+3.68 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 172.44 | 33 | 5,691 | 924,718 | 924.8 K to 924.7 K (0.00 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 174.38 | 2,190 | 381,892 | 924,751 | 926.9 K to 924.8 K (-0.24 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 174.25 | 3,000 | 522,750 | 926,941 | 929.9 K to 926.9 K (-0.32 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.38 | 608 | 106,023 | 117,243 | 117.9 K to 117.2 K (-0.52 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.02 | 765 | 133,125 | 117,851 | 118.6 K to 117.9 K (-0.64 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.37 | 676 | 117,874 | 155,706 | 156.4 K to 155.7 K (-0.43 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.06 | 895 | 155,784 | 156,382 | 157.3 K to 156.4 K (-0.57 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 172.79 | 4 | 691 | 16,065 | 16.1 K to 16.1 K (-0.02 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 174.38 | 203 | 35,399 | 16,069 | 16.3 K to 16.1 K (-1.25 %) |